Results 81 to 90 of about 2,951,417 (247)

Immunoglobulin Depletion and Recovery Following Blinatumomab in Infants With KMT2A‐Rearranged ALL

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Adding blinatumomab to standard chemotherapy for infants with KMT2A‐rearranged acute B‐cell lymphoblastic leukemia (KMT2A‐r B‐ALL) improves outcomes. Although blinatumomab impairs immunoglobulin G (lgG) production, increasing infection susceptibility, IgG recovery remains poorly understood.
Miguel Vieira Martins   +14 more
wiley   +1 more source

Long-term outcomes and risk assessment of immediate implants at molar extraction sites in a Taiwan population

open access: yesScientific Reports
This long-term retrospective study evaluated the clinical and radiographic outcomes and assessed the risks associated with immediate molar implants (IMI) in a Taiwan population.
Shing-Zeng Dung   +3 more
doaj   +1 more source

Unicystic Ameloblastoma: Treatment Outcomes and Risk of Recurrence – A 19-Year Institution-Based Study

open access: yesJournal of Indian Academy of Oral Medicine and Radiology
Background and Aim: Unicystic ameloblastoma (UA) is a variant of ameloblastoma; although benign, it is believed to be a destructive tumor, is locally invasive, and presents a high rate of recurrence.
Palati Sinduja, Pratibha Ramani
doaj   +1 more source

Impact of Metastatic Patterns on Survival and Response to Therapy in Neuroblastoma

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background While the presence of metastases in neuroblastoma (NB) is a well‐established prognostic factor, the clinical significance of dissemination patterns and tumour burden and their impact on response and survival remains poorly understood.
Mariona Morell‐Daniel   +15 more
wiley   +1 more source

Inpatient Exposure, Confidence, and Knowledge in Pediatric Hematology/Oncology: Evaluating General Pediatric Residents During 2025 ACGME Curriculum Change

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background General pediatricians often evaluate hematologic and oncologic presentations before subspecialty consultation, yet the 2025 Accreditation Council for Graduate Medical Education (ACGME) pediatric requirements reduce inpatient pediatric hematology/oncology (PHO) time, raising questions about resident readiness.
Colburn Yu, Rohini Jain
wiley   +1 more source

Feasibility of Follow-Up Studies and Reclassification in Spinocerebellar Ataxia Gene Variants of Unknown Significance. [PDF]

open access: yesFront Genet, 2022
Ghorbani F   +13 more
europepmc   +1 more source

Consensus Standards and Recommendations for Developmental and Cognitive Surveillance, Screening, and Evaluation in Sickle Cell Disease: Executive Summary From the National Alliance of Sickle Cell Centers Neurocognitive Workgroup

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Neurodevelopmental and neurocognitive difficulties are prevalent among individuals with sickle cell disease and warrant prompt identification and support. This Special Report provides an executive summary of standards and recommendations for surveillance, screening, and evaluation for development and cognition across the lifespan developed by ...
Alyssa M. Schlenz   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy